Crystalline escitalopram hydrobromide and methods for preparing the same
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- H LUNDBECK AS
- Publication Date
- 2006-01-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
[0001] The present invention relates to escitalopram in the hydrobromide form, which is the S-enantiomer of the known antidepressant citalopram, i.e. (S)-1-[3-(dimethylamino)propyl]- 1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuronitrile, and a method for its preparation. Background of the invention
[0002] Citalopram is a well known antidepressant that has been on the market for many years and has the following structure:
[0003]
[0004] It is a selective, centrally acting serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor with corresponding antidepressant activity. Citalopram was first disclosed in DE 2,657,013 (equivalent to US 4,136,193).
[0005] Diol, 4-[4-(dimethylamino)-1-(4'-fluorophenyl)-1-hydroxy-1-butyl]-3-(hydroxymethyl)-benzonitrile, and its preparation as The use of intermediates of citalopram has been disclosed, for example, in US Pat. No. 4,650,884.
[0006] S-enantiomer of formula (escitalopram)
[0007]
[0008] and the antidepressant effect...